Iron overload diminishes atherosclerosis in apoE-deficient mice

被引:75
作者
Kirk, EA
Heinecke, JW
LeBoeuf, RC
机构
[1] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Nutr Sci, Seattle, WA 98195 USA
[3] Washington Univ, Dept Med, St Louis, MO USA
[4] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO USA
关键词
D O I
10.1172/JCI7664
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It has been proposed that elevated levels of tissue iron increase the risk for atherosclerosis, perhaps by favoring the formation of pro-atherogenic oxidized LDL. Working with apoE-deficient (apoE(-/-)) mice, which do not require a high-fat diet to develop atherosclerosis, we compared the effects of standard diet (0.02% iron) or a 2% carbonyl iron diet. After 24 weeks, mice fed the 2% carbonyl iron diet had twice as much iron in their plasma, a ninefold increase in bleomycin-detectable free iron in their plasma, and ten times as much iron in their livers as control mice. Dietary iron overload caused a modest (30%) rise in plasma triglyceride and cholesterol. Nevertheless, this regimen did not exacerbate, but rather reduced the severity of atherosclerosis by 50%, and it failed to elevate hepatic levels of heme oxygenase mRNA, which is induced by many different oxidative insults in vitro. Moreover, hepatic levels of protein-bound dityrosine and ortho-tyrosine, two markers of metal-catalyzed oxidative damage in vitro, failed to rise in iron-overloaded animals. Our observations suggest that elevated serum and tissue levels of iron are not atherogenic in apoE(-/-) mice. Moreover, they call into question the hypothesis that elevated levels of tissue iron promote LDL oxidation and oxidative stress in vivo.
引用
收藏
页码:1545 / 1553
页数:9
相关论文
共 53 条
[1]  
Annichino-Bizzacchi JM, 2000, J CARDIOVASC RISK, V7, P37
[2]   IRON OVERLOAD AUGMENTS THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN RABBITS [J].
ARAUJO, JA ;
ROMANO, EL ;
BRITO, BE ;
PARTHE, V ;
ROMANO, M ;
BRACHO, M ;
MONTANO, RF ;
CARDIER, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1172-1180
[3]   HEMIN - A POSSIBLE PHYSIOLOGICAL MEDIATOR OF LOW-DENSITY-LIPOPROTEIN OXIDATION AND ENDOTHELIAL INJURY [J].
BALLA, G ;
JACOB, HS ;
EATON, JW ;
BELCHER, JD ;
VERCELLOTTI, GM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1700-1711
[4]   Haemochromatosis gene mutations and risk of coronary artery disease [J].
Battiloro, E ;
Ombres, D ;
Pascale, E ;
D'Ambrosio, E ;
Verna, R ;
Arca, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (05) :389-392
[5]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[6]  
BOTHWELL TH, 1979, IRON METABOLISM MAN, P79
[7]   KOCHS POSTULATES FOR CHOLESTEROL [J].
BROWN, MS ;
GOLDSTEIN, JL .
CELL, 1992, 71 (02) :187-188
[8]   HFE gene mutations in coronary atherothrombotic disease [J].
Calado, RT ;
Franco, RF ;
Pazin, A ;
Simöes, MV ;
Marin-Neto, JA ;
Zago, MA .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (03) :301-306
[9]   Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit [J].
Dabbagh, AJ ;
Shwaery, GT ;
Keaney, JF ;
Frei, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2638-2645
[10]  
Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.0.CO